258 related articles for article (PubMed ID: 34117807)
1. Clinical features, diagnosis, and survival analysis of dogs with glioma.
José-López R; Gutierrez-Quintana R; de la Fuente C; Manzanilla EG; Suñol A; Pi Castro D; Añor S; Sánchez-Masian D; Fernández-Flores F; Ricci E; Marioni-Henry K; Mascort J; Matiasek LA; Matiasek K; Brennan PM; Pumarola M
J Vet Intern Med; 2021 Jul; 35(4):1902-1917. PubMed ID: 34117807
[TBL] [Abstract][Full Text] [Related]
2. The T2-FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs.
Garcia-Mora J; Parker RL; Cecere T; Robertson JL; Rossmeisl JH
J Vet Intern Med; 2023; 37(4):1447-1454. PubMed ID: 37246729
[TBL] [Abstract][Full Text] [Related]
3. Canine intracranial gliomas: relationship between magnetic resonance imaging criteria and tumor type and grade.
Bentley RT; Ober CP; Anderson KL; Feeney DA; Naughton JF; Ohlfest JR; O'Sullivan MG; Miller MA; Constable PD; Pluhar GE
Vet J; 2013 Nov; 198(2):463-71. PubMed ID: 24051197
[TBL] [Abstract][Full Text] [Related]
4. Machine learning predicts histologic type and grade of canine gliomas based on MRI texture analysis.
Barge P; Oevermann A; Maiolini A; Durand A
Vet Radiol Ultrasound; 2023 Jul; 64(4):724-732. PubMed ID: 37133981
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.
Young BD; Levine JM; Porter BF; Chen-Allen AV; Rossmeisl JH; Platt SR; Kent M; Fosgate GT; Schatzberg SJ
Vet Radiol Ultrasound; 2011; 52(2):132-41. PubMed ID: 21388463
[TBL] [Abstract][Full Text] [Related]
6. Association of magnetic resonance imaging-based preoperative tumor volume with postsurgical survival time in dogs with primary intracranial glioma.
MacLellan JD; Arnold SA; Dave AC; Hunt MA; Pluhar GE
J Am Vet Med Assoc; 2018 Jan; 252(1):98-102. PubMed ID: 29244602
[TBL] [Abstract][Full Text] [Related]
7. Inter-pathologist agreement on diagnosis, classification and grading of canine glioma.
Krane GA; Shockley KR; Malarkey DE; Miller AD; Miller CR; Tokarz DA; Jensen HL; Janardhan KS; Breen M; Mariani CL
Vet Comp Oncol; 2022 Dec; 20(4):881-889. PubMed ID: 35856268
[TBL] [Abstract][Full Text] [Related]
8. Prognostic histopathologic features of canine glial tumors.
Merickel JL; Pluhar GE; Rendahl A; O'Sullivan MG
Vet Pathol; 2021 Sep; 58(5):945-951. PubMed ID: 34219560
[TBL] [Abstract][Full Text] [Related]
9. Glioma with cribriform plate involvement in 6 dogs.
Reyes VAA; Howerth EW; Blas-Machado U; Platt SR; Pavarini SP; Castro LT; Church ME; Rissi DR
J Vet Diagn Invest; 2023 Nov; 35(6):800-805. PubMed ID: 37608783
[TBL] [Abstract][Full Text] [Related]
10. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
[TBL] [Abstract][Full Text] [Related]
11. Grading of oligodendroglioma in dogs based on magnetic resonance imaging.
Amphimaque B; Durand A; Oevermann A; Vidondo B; Schweizer D
J Vet Intern Med; 2022 Nov; 36(6):2104-2112. PubMed ID: 36366870
[TBL] [Abstract][Full Text] [Related]
12. Relationship between histological tumor margins and magnetic resonance imaging signal intensities in brain neoplasia of dogs.
Johnson PJ; Rivard BC; Wood JH; DiRubio ML; Henry JG; Miller AD
J Vet Intern Med; 2022 May; 36(3):1039-1048. PubMed ID: 35488504
[TBL] [Abstract][Full Text] [Related]
13. Computed tomographic characteristics of primary brain tumors in 50 dogs.
Turrel JM; Fike JR; LeCouteur RA; Higgins RJ
J Am Vet Med Assoc; 1986 Apr; 188(8):851-6. PubMed ID: 3710874
[TBL] [Abstract][Full Text] [Related]
14. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
15. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).
Debreuque M; De Fornel P; David I; Delisle F; Ducerveau MN; Devauchelle P; Thibaud JL
BMC Vet Res; 2020 Oct; 16(1):412. PubMed ID: 33129320
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
17. Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas.
Garcia Mora JK; Robertson J; Hsu FC; Shinn RL; Larson MM; Rylander CG; Whitlow CT; Debinski W; Davalos RV; B Daniel G; Rossmeisl JH
J Vet Intern Med; 2022 May; 36(3):1066-1074. PubMed ID: 35274379
[TBL] [Abstract][Full Text] [Related]
18. A methodological approach for deep learning to distinguish between meningiomas and gliomas on canine MR-images.
Banzato T; Bernardini M; Cherubini GB; Zotti A
BMC Vet Res; 2018 Oct; 14(1):317. PubMed ID: 30348148
[TBL] [Abstract][Full Text] [Related]
19. Canine spinal cord glioma.
Rissi DR; Barber R; Burnum A; Miller AD
J Vet Diagn Invest; 2017 Jan; 29(1):126-132. PubMed ID: 28074710
[TBL] [Abstract][Full Text] [Related]
20. Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging.
Kraft SL; Gavin PR; DeHaan C; Moore M; Wendling LR; Leathers CW
J Vet Intern Med; 1997; 11(4):218-25. PubMed ID: 9298476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]